Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Chiu

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 30, 2024
How to develop a controlled human infection model for Clostridioides difficileAnnefleur D O Hensen, Maria J G T Vehreschild, Dale N Gerding, et al.
Cell Genomics|December 5, 2022
Single-cell genome-wide association reveals that a nonsynonymous variant in <i>ERAP1</i> confers increased susceptibility to influenza virusBenjamin H Schott, Liuyang Wang, Xinyu Zhu, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 10, 2024
Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023Marco Cavaleri, David Kaslow, Eric Boateng, et al.
American Journal of Respiratory and Critical Care Medicine|July 13, 2021
Innate-like Gene Expression of Lung-Resident Memory CD8<sup>+</sup> T Cells during Experimental Human Influenza: A Clinical StudySuzanna Paterson, Satwik Kar, Seng Kuong Ung, et al.
Npj Viruses|June 20, 2025
Longitudinal kinetics of the viral infection biomarker 3'-deoxy-3',4'-didehydro-cytidine in SARS-CoV-2, influenza A virus and RSV human challenge modelsRavi Mehta, Elena Chekmeneva, Stephanie Ascough, et al.
Frontiers in Immunology|May 20, 2022
Pandemic, Epidemic, Endemic: B Cell Repertoire Analysis Reveals Unique Anti-Viral Responses to SARS-CoV-2, Ebola and Respiratory Syncytial VirusAlexander Stewart, Emma Sinclair, Joseph Chi-Fung Ng, et al.
The New England Journal of Medicine|October 6, 2016
Daratumumab, Lenalidomide, and Dexamethasone for Multiple MyelomaMeletios A Dimopoulos, Albert Oriol, Hareth Nahi, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 13, 2024
Fourth Controlled Human Infection Model (CHIM) meeting - CHIMs in endemic countries, May 22-23, 2023Melissa Kapulu, Lucinda Manda-Taylor, Shobana Balasingam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2022
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II TrialCatherine Thieblemont, Tycel Phillips, Herve Ghesquieres, et al.
Leukemia|May 28, 2020
Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumabTineke Casneuf, Homer C Adams, Niels W C J van de Donk, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 30, 2024
How to develop a controlled human infection model for Clostridioides difficileAnnefleur D O Hensen, Maria J G T Vehreschild, Dale N Gerding, et al.
Cell Genomics|December 5, 2022
Single-cell genome-wide association reveals that a nonsynonymous variant in <i>ERAP1</i> confers increased susceptibility to influenza virusBenjamin H Schott, Liuyang Wang, Xinyu Zhu, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 10, 2024
Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023Marco Cavaleri, David Kaslow, Eric Boateng, et al.
American Journal of Respiratory and Critical Care Medicine|July 13, 2021
Innate-like Gene Expression of Lung-Resident Memory CD8<sup>+</sup> T Cells during Experimental Human Influenza: A Clinical StudySuzanna Paterson, Satwik Kar, Seng Kuong Ung, et al.
Npj Viruses|June 20, 2025
Longitudinal kinetics of the viral infection biomarker 3'-deoxy-3',4'-didehydro-cytidine in SARS-CoV-2, influenza A virus and RSV human challenge modelsRavi Mehta, Elena Chekmeneva, Stephanie Ascough, et al.
Frontiers in Immunology|May 20, 2022
Pandemic, Epidemic, Endemic: B Cell Repertoire Analysis Reveals Unique Anti-Viral Responses to SARS-CoV-2, Ebola and Respiratory Syncytial VirusAlexander Stewart, Emma Sinclair, Joseph Chi-Fung Ng, et al.
The New England Journal of Medicine|October 6, 2016
Daratumumab, Lenalidomide, and Dexamethasone for Multiple MyelomaMeletios A Dimopoulos, Albert Oriol, Hareth Nahi, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 13, 2024
Fourth Controlled Human Infection Model (CHIM) meeting - CHIMs in endemic countries, May 22-23, 2023Melissa Kapulu, Lucinda Manda-Taylor, Shobana Balasingam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2022
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II TrialCatherine Thieblemont, Tycel Phillips, Herve Ghesquieres, et al.
Leukemia|May 28, 2020
Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumabTineke Casneuf, Homer C Adams, Niels W C J van de Donk, et al.
Pageof 13